94% of physicians believe mHealth is improving patient safety, outcomes

The majority of physicians (94 percent) and hospital leaders (90 percent) believe mobile technology is improving patient safety and outcomes, according to a survey conducted by Black Book.

The significant majority of physicians (94 percent) and hospital leaders (90 percent) believe mobile technology improves patient safety and outcomes, according to a survey conducted by Black Book.

The survey included responses from 770 hospital-based users and 1,279 individuals in physician practices. Researchers aimed to provide an overview of cybersecurity and secure communications.

Additional findings included:

  • 63 percent of respondents reported challenges with general mobile adoption strategies and enterprise technology execution.
  • 85 percent of hospitals and 83 percent of physician practices are engaged with secure communication platforms between care teams, patients and families.
  • 96 percent of hospitals are budgeting or investing in comprehensive communication platforms.
  • 30 percent of respondents reported receiving texts that contained individually identifiable information such as patient birthdays, initials or names from unsecured sources about once a day.
  • 98 percent of hospitals and 77 percent of physician practices reported using intrusion detection systems and secure emailing.

“When relying on cloud services and third-party servers to manage and route messages, end-to-end encryption that reflect HIPAA’s privacy and security requirements exchanging health data are safeguarding against breaches,” said Doug Brown, president of Black Book Market Research. “Stakeholders across the healthcare industry are in the quest of finding solutions to use comprehensive real-time data and connectivity cleverly to advance patient safety, productivity and profitability. Organizations are adopting secure text messaging platforms because texts are convenient, as well.”

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.